Related Experiment Video
Updated: Mar 13, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Eucalyptol and Its Role in Chronic Diseases.
1Department of Basic Nursing Science, School of Nursing, Korea University, Seoul, 02841, Republic of Korea. ghseol@korea.ac.kr.
Eucalyptol, a compound from Eucalyptus, shows anti-inflammatory and antioxidant effects beneficial for chronic diseases. Its properties suggest potential as a novel therapeutic agent for conditions like cardiovascular and neurodegenerative diseases.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Immunology
Background:
- Chronic diseases are often driven by chronic inflammation and oxidative stress.
- Existing treatments may be supplemented by therapies like aromatherapy.
- Eucalyptol (1,8-cineole) possesses anti-inflammatory and antioxidant properties.
Purpose of the Study:
- To review the therapeutic potential of eucalyptol in managing chronic diseases.
- To explore the mechanisms underlying eucalyptol's anti-inflammatory and antioxidant effects.
- To assess eucalyptol's utility as a drug carrier for brain delivery.
Main Methods:
- Review of existing studies on eucalyptol's effects in various disease models (cell, animal, human).
- Analysis of eucalyptol's impact on inflammatory pathways (NF-κB, TNF-α, IL-1β, IL-6, ERK).
- Investigation of eucalyptol's antioxidant mechanisms, including radical scavenging.
Main Results:
- Eucalyptol demonstrated significant anti-inflammatory and antioxidant effects across multiple disease models.
- It suppresses key pro-inflammatory mediators and reduces oxidative stress.
- Eucalyptol can cross the blood-brain barrier, indicating potential for targeted brain drug delivery.
Conclusions:
- Eucalyptol's anti-inflammatory and antioxidant properties make it a promising candidate for treating chronic inflammatory and oxidative stress-related diseases.
- Its ability to penetrate the blood-brain barrier enhances its therapeutic potential, particularly for neurological conditions.
- Further development of eucalyptol-based therapies could offer new treatment options for chronic diseases.
More Related Videos
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-I: Introduction